342 related articles for article (PubMed ID: 10406979)
1. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
Hawkins SA; McDonnell GV
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):148-52. PubMed ID: 10406979
[TBL] [Abstract][Full Text] [Related]
2. Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
Fabis-Pedrini MJ; James I; Seewann A; Yau WY; van de Bovenkamp AA; Sanders FRK; Qiu W; Burton J; Mastaglia FL; Carroll WM; Kermode AG
J Neurol Sci; 2018 May; 388():12-18. PubMed ID: 29627005
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Sayao AL; Devonshire V; Tremlett H
Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
Deryck O; Ketelaer P; Dubois B
J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.
McDonnell GV; Hawkins SA
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):451-4. PubMed ID: 9576534
[TBL] [Abstract][Full Text] [Related]
7. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
[TBL] [Abstract][Full Text] [Related]
8. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
9. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
Sartori A; Abdoli M; Freedman MS
J Neurol; 2017 Jun; 264(6):1068-1075. PubMed ID: 28417192
[TBL] [Abstract][Full Text] [Related]
10. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
Crielaard L; Kavaliunas A; Ramanujam R; Olsson T; Hillert J; Stridh P; Kockum I; Manouchehrinia A
J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):761-767. PubMed ID: 30824631
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
[TBL] [Abstract][Full Text] [Related]
13. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
Costelloe L; Thompson A; Walsh C; Tubridy N; Hutchinson M
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1245-8. PubMed ID: 18477712
[TBL] [Abstract][Full Text] [Related]
15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis in Northern Ireland: a historical and global perspective.
McDonnell GV; Hawkins SA
Ulster Med J; 2000 Nov; 69(2):97-105. PubMed ID: 11196738
[TBL] [Abstract][Full Text] [Related]
17. Benign multiple sclerosis in Crete.
Mastorodemos V; Nikolakaki H; Tzagournissakis M; Kotzamani D; Panou T; Spanaki C; Klados G; Maris T; Kontolaimaki E; Psaroudaki K; Chlouverakis G; Georgakakis G; Plaitakis A
Mult Scler; 2010 Jun; 16(6):701-6. PubMed ID: 20237192
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
El-Salem K; Khader Y
Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
[TBL] [Abstract][Full Text] [Related]
20. Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
Mathey G; Pisché G; Soudant M; Pittion-Vouyovitch S; Guillemin F; Debouverie M; Epstein J
J Neurol; 2021 Oct; 268(10):3817-3825. PubMed ID: 33791847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
